EnerSpar Corp. (TSE:NRX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NurExone Biologic Inc. shareholders showed strong support for company proposals during the 2024 Annual Meeting, with over 99% approval for all resolutions including director elections, auditor reappointment, and amendments to the equity incentive plan. Additionally, the company announced significant grants of stock options and restricted share units to various team members under the Equity Incentive Plan.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.